• APVO Q1 2026 Earnings: EPS Misses Estimates Amid Ongoing Clinical Development - Revenue Growth Outlook dars.gov.et Wed, 08 Jul 2026 15:44:41 GMT
• Aptevo Therapeutics Inc (APVO) Earnings Forecast: Future EPS & Revenue Growth Estimates TradingKey Tue, 07 Jul 2026 07:00:00 GMT
• Aptevo Therapeutics (APVO) Edges Higher: Testing Key Resistance Amid Steady Volume - BPI Reversal dars.gov.et Sun, 05 Jul 2026 18:30:40 GMT
• Aptevo Therapeutics Q1 2026 Earnings: Wider-than-Expected Loss Amid Ongoing Pre-Revenue Phase - Dividend Earnings Report dars.gov.et Thu, 02 Jul 2026 09:35:43 GMT
• Aptevo Therapeutics Secures Grant for APVO451 Development The Globe and Mail Wed, 01 Jul 2026 20:50:00 GMT
• Aptevo Therapeutics awarded $1.5M research grant from Andy Hill CARE Fund TipRanks Wed, 01 Jul 2026 00:25:24 GMT
• Aptevo Secures $1.5 Million Non-Dilutive Research Grant From the Andy Hill Care Fund to Advance APVO451, a Nectin-4-Targeted Trisp... The Globe and Mail Tue, 30 Jun 2026 12:05:00 GMT
• Aptevo (NASDAQ: APVO) gets $1.5M CARE Fund grant to advance APVO451 Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
• Aptevo receives $1.5M grant for cancer therapy development Investing.com Tue, 30 Jun 2026 07:00:00 GMT
• Price to sales forward of Aptevo Therapeutics Inc. – NASDAQ:APVO TradingView Sun, 28 Jun 2026 23:22:25 GMT
• price to earnings forward of aptevo therapeutics inc. – nasdaq:apvo TradingView Sat, 27 Jun 2026 14:41:24 GMT
• aptevo therapeutics, inc. actuals & estimates (nasdaq:apvo) TradingView Fri, 26 Jun 2026 19:12:15 GMT
• aptevo therapeutics, inc. actuals & estimates (fwb:ap82) TradingView Thu, 25 Jun 2026 22:21:53 GMT
• aptevo therapeutics inc (apvo) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• Niowave holds 12.18% of Aptevo (NASDAQ: APVO) — 151,723 shares Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• NIOWAVE, INC. (NASDAQ: APVO) discloses 98,522 shares and $8 warrants Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• form 13g aptevo therapeutics inc. for: 22 june by investing.com Investing.com UK Mon, 22 Jun 2026 07:00:00 GMT
• aptevo therapeutics inc (apvo) earnings forecast: future eps & revenue growth estimates TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• Aptevo Therapeutics Inc (APVO) Technical Analysis: Support, Resistance, Indicators & Moving Averages TradingKey Thu, 18 Jun 2026 09:27:09 GMT
• aptevo therapeutics inc (apvo) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 09:18:17 GMT
• apvo stock tuesday madness! (finally something) aptevo therapeutics billy bob thornton restricted diet (dfhbdaw94q) Fathom Journal Thu, 18 Jun 2026 02:44:10 GMT
• aptevo therapeutics inc (apvo) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 21:51:20 GMT
• aptevo therapeutics inc (apvo) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 21:48:29 GMT
• aptevo therapeutics inc (apvo) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 15:40:54 GMT
• aptevo therapeutics inc (apvo) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 11:22:27 GMT
• aptevo therapeutics inc (apvo) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 11:12:16 GMT
• apvo q1 2026 earnings: eps misses estimates amid pre-revenue clinical focus - share repurchase impact newsline.com Tue, 16 Jun 2026 14:40:15 GMT
• aptevo therapeutics inc (apvo) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• aptevo therapeutics inc (apvo) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• aptevo therapeutics inc (apvo) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• aptevo and niowave partner to advance radiopharmaceutical cancer therapies citybuzz - Tue, 09 Jun 2026 21:47:00 GMT
• As Big Pharma Bets On Radiopharmaceuticals, Aptevo And Niowave Join Forces To Advance Novel Targeted Cancer Therapeutics In The $1... NewMediaWire Tue, 09 Jun 2026 07:00:00 GMT
• aptevo therapeutics (apvo) slips 1.43% as shares approach support at $4.66 - oversold bounce ideas The Legal Advocate Sun, 31 May 2026 19:32:12 GMT
• Aptevo Therapeutics (APVO) Holds Near Support After Modest Decline - Hedge Fund Favorites dars.gov.et Sat, 30 May 2026 07:00:00 GMT
• APVO Q1 2026 Earnings: Wider-than-Expected Loss as Clinical-Stage Biotech Reports No Revenue dars.gov.et Sat, 30 May 2026 07:00:00 GMT
• aptevo therapeutics (apvo) slips 1.43% as shares test key support near $4.66 - supertrend flip dars.gov.et Sat, 30 May 2026 07:00:00 GMT
• aptevo therapeutics (apvo) slides lower as support level comes into focus - fundamental weighted newsline.com Fri, 29 May 2026 07:00:00 GMT
• aptevo therapeutics dip continues as stock consolidates near key support - etf aum growth Město Břeclav Fri, 29 May 2026 07:00:00 GMT
• apvo q1 2026 earnings: eps misses estimates as pre-revenue biotech faces headwinds - pretax income report newsline.com Fri, 29 May 2026 07:00:00 GMT
• aptevo therapeutics (apvo) svp, cso files form 3 reporting zero shares Stock Titan Fri, 29 May 2026 00:05:51 GMT
• aptevo and niowave launch strategic collaboration for radiopharmaceutical therapeutic development, includes strategic equity inves... Black Hills Pioneer Thu, 28 May 2026 09:00:00 GMT
• Aptevo Therapeutics Appoints Mary J. Janatpour, Ph.D., as Senior Vice President & Chief Scientific Officer ACCESS Newswire Thu, 28 May 2026 07:00:00 GMT
• Aptevo Therapeutics Names Mary Janatpour Chief Scientific Officer as It Expands Beyond Core Immuno-Oncology Programs citybiz Thu, 28 May 2026 07:00:00 GMT
• aptevo names mary janatpour as chief scientific officer Investing.com Thu, 28 May 2026 07:00:00 GMT
• oncology r&d leader to guide aptevo's multispecific cancer pipeline Stock Titan Thu, 28 May 2026 07:00:00 GMT
• aptevo therapeutics (apvo) svp, cso files form 3 reporting zero shares Stock Titan Thu, 28 May 2026 07:00:00 GMT
• seattle biotech lands investment, collaboration deal for cancer treatments The Business Journals Thu, 28 May 2026 04:18:00 GMT
• aptevo and niowave partner to develop radiopharmaceuticals; niowave to invest in aptevo geneonline.com Wed, 27 May 2026 23:34:21 GMT
• Seattle biotech lands investment, collaboration deal for cancer treatments The Business Journals Wed, 27 May 2026 07:00:00 GMT
• Niowave takes 7.9% Aptevo stake in cancer radiopharma tie-up Stock Titan Wed, 27 May 2026 07:00:00 GMT
• Aptevo and Niowave launch radiopharmaceuticals collaboration The Pharma Letter Wed, 27 May 2026 07:00:00 GMT
• Aptevo and Niowave Launch Strategic Collaboration for Radiopharmaceutical Therapeutic Development, Includes Strategic Equity Inves... Newswire.com Wed, 27 May 2026 07:00:00 GMT
• aptevo, niowave form 50/50 partnership for cancer drugs Investing.com Wed, 27 May 2026 07:00:00 GMT
• aptevo forms strategic radiopharmaceutical collaboration with niowave TipRanks Wed, 27 May 2026 07:00:00 GMT
• apvo q1 2026 earnings: eps miss widens as revenue remains absent - mid-term outlook newsline.com Wed, 27 May 2026 07:00:00 GMT
• aptevo therapeutics (apvo) forms strategic collaboration with ni GuruFocus Wed, 27 May 2026 07:00:00 GMT
• aptevo (apvo) signs niowave radiopharma pact and $0.5m equity deal Stock Titan Wed, 27 May 2026 07:00:00 GMT
• aptevo, niowave launch collab for radiopharmaceutical oncology programs TipRanks Wed, 27 May 2026 07:00:00 GMT
• apvo q1 2026 earnings: stock rises despite wider-than-expected loss as pipeline progress takes center stage newsline.com Fri, 22 May 2026 07:00:00 GMT
• apvo q1 2026 earnings: stock gains sharply despite wider-than-expected loss - share dilution risk The Legal Advocate Fri, 22 May 2026 00:45:36 GMT
• apvo q1 2026 earnings: stock gains sharply despite wider-than-expected loss - earnings miss alert newsline.com Thu, 21 May 2026 07:00:00 GMT
• aptevo (apvo) q1 2026 earnings: soft quarter raises questions - earnings preview The Legal Advocate Thu, 21 May 2026 07:00:00 GMT
• all you need to know about aptevo therapeutics (apvo) rating upgrade to buy Yahoo Finance Wed, 20 May 2026 07:00:00 GMT
• aptevo (apvo) q1 2026 earnings miss by significant: key takeaways - profit margin analysis newsline.com Tue, 19 May 2026 07:00:00 GMT
• aptevo (apvo) q1 2026 results miss estimates — eps $-6.41 vs $-5.71 - {璐㈡姤鍓爣棰榼 Newser Tue, 19 May 2026 04:48:10 GMT
• key facts: aptevo q1 loss $0.01/sh; mipletamig shows 87% clinical benefit TradingView Thu, 14 May 2026 07:55:34 GMT
• roth mkm maintains aptevo therapeutics(apvo.us) with buy rating, maintains target price $21 Moomoo Thu, 14 May 2026 07:00:00 GMT
• aptevo reports clinical trial results for aml drug candidate by investing.com Investing.com India Thu, 14 May 2026 03:30:28 GMT
• aptevo (apvo) positioned for growth with promising pipeline and leadership GuruFocus Thu, 14 May 2026 02:17:25 GMT
• aptevo therapeutics updates on q1 2026 progress and leadership t GuruFocus Wed, 13 May 2026 18:22:30 GMT
• aptevo (apvo) positioned for growth with promising pipeline and leadership GuruFocus Wed, 13 May 2026 17:31:28 GMT
• aptevo therapeutics reports q1 cash and cash equivalents $14.5m TipRanks Wed, 13 May 2026 16:51:29 GMT
• aptevo therapeutics inc reports results for the quarter ended march 31 - earnings summary TradingView Wed, 13 May 2026 07:00:00 GMT
• aptevo therapeutics provides a 1q26 business update; rainier on track for 2026 completion and phase 2 dose selection ACCESS Newswire Wed, 13 May 2026 07:00:00 GMT
• leukemia trial hits 81% remission; aptevo lines up $60m equity line Stock Titan Wed, 13 May 2026 07:00:00 GMT
• aptevo reports clinical trial results for aml drug candidate Investing.com Wed, 13 May 2026 07:00:00 GMT
• aptevo therapeutics: q1 2026 update — $14.5m cash, $60m equity line to fund pipeline TradingView Wed, 13 May 2026 07:00:00 GMT
• strong aml data and $60m equity facility in aptevo (nasdaq: apvo) q1 update Stock Titan Wed, 13 May 2026 07:00:00 GMT
• aptevo therapeutics (nasdaq: apvo) warns on going concern after $6.7m q1 loss Stock Titan Wed, 13 May 2026 07:00:00 GMT
• apvo price today: aptevo therapeutics inc. stock price, quote & chart | mexc MEXC Wed, 13 May 2026 06:44:21 GMT
• number of shareholders of aptevo therapeutics, inc. – gettex:ap82 TradingView Mon, 11 May 2026 20:27:27 GMT
• aptevo therapeutics inc expected to post a loss of $5.60 a share - earnings preview TradingView Fri, 08 May 2026 23:28:04 GMT
• the opportunity most miss about aptevo (apvo) (selling pressure) 2026-05-08 - continuation pattern picks newsline.com Fri, 08 May 2026 07:00:00 GMT
• aptevo therapeutics (apvo) reports encouraging results in aml tr GuruFocus Fri, 08 May 2026 05:15:00 GMT
• aptevo reports 87% clinical benefit in frontline aml patients in rainier trial TipRanks Thu, 07 May 2026 14:54:22 GMT
• aptevo reports strong remission data in frontline aml trial as rainier study advances toward phase 2 BioPharm International Thu, 07 May 2026 07:00:00 GMT
• 6 AML patients reached transplant as Aptevo enters final dose stage Stock Titan Wed, 06 May 2026 07:00:00 GMT
• aptevo (nasdaq: apvo) reports 81% aml remission in rainier study Stock Titan Wed, 06 May 2026 07:00:00 GMT
• aptevo reports 87% clinical benefit and 81% remission in 31 evaluable frontline aml patients through cohort 5, substantially outpe... ACCESS Newswire Wed, 06 May 2026 07:00:00 GMT
• aptevo reports 87% clinical benefit in frontline aml patients in rainier trial TipRanks Wed, 06 May 2026 07:00:00 GMT
• apvo forecast, price target & analyst ratings | aptevo therapeutics inc (nasdaq:apvo) ChartMill Fri, 01 May 2026 07:00:00 GMT
• aptevo therapeutics (apvo) price target decreased by 99.72% to 21.42 MSN Wed, 29 Apr 2026 07:20:56 GMT
• aptevo therapeutics announces $8m at-the-market equity offering with warrants; shares more than double MSN Mon, 27 Apr 2026 15:04:32 GMT
• aptevo therapeutics shares jump after $60 million equity facility secured MSN Mon, 27 Apr 2026 14:41:46 GMT
• aptevo therapeutics announces $8m at-the-market equity offering with warrants; shares more than double MSN Sun, 26 Apr 2026 23:42:32 GMT
• aptevo therapeutics shares jump after $60 million equity facility secured MSN Sun, 26 Apr 2026 01:51:40 GMT
• apvo forecast, price target & analyst ratings | aptevo therapeutics inc (nasdaq:apvo) ChartMill Fri, 24 Apr 2026 07:00:00 GMT
• apvo aptevo therapeutics inc. reports vastly stronger q4 2025 eps than expected, shares climb 7.16 percent today. - social trade s... Xã Thanh Hà Thu, 23 Apr 2026 03:40:36 GMT
• aptevo therapeutics posts 99.9% eps surprise far narrower loss than expected Cổng thông tin điện tử tỉnh Lào Cai Thu, 23 Apr 2026 00:32:22 GMT
• aptevo therapeutics posts 99.9% eps surprise far narrower loss than expected Xã Thanh Hà Wed, 22 Apr 2026 18:42:18 GMT
• aptevo (apvo) stock technical trade (investors pile in) 2026-04-22 - safe entry stocks The Legal Advocate Wed, 22 Apr 2026 07:00:00 GMT
• aptevo (apvo) stock: fast summary (weakens) 2026-04-20 - fast moving stocks UBND thành phố Hải Phòng Tue, 21 Apr 2026 02:45:42 GMT
• aptevo therapeutics announces $8m at-the-market equity offering with warrants; shares more than double MSN Mon, 20 Apr 2026 19:49:28 GMT
• aptevo (apvo) stock: fast summary (weakens) 2026-04-20 - low vol etf newsline.com Mon, 20 Apr 2026 07:00:00 GMT
• aptevo therapeutics announces $8m at-the-market equity offering with warrants; shares more than double MSN Sat, 18 Apr 2026 22:48:47 GMT
• aptevo therapeutics announces $8m at-the-market equity offering with warrants; shares more than double MSN Thu, 16 Apr 2026 12:57:49 GMT
• aptevo therapeutics posts 99.9% eps surprise far narrower loss than expected - gaap earnings report newsline.com Thu, 16 Apr 2026 07:00:00 GMT
• apvo aptevo therapeutics inc. reports vastly stronger q4 2025 eps than expected, shares climb 7.16 percent today. - pre-announceme... newsline.com Wed, 15 Apr 2026 07:00:00 GMT
• risk on: is aptevo therapeutics inc impacted by rising rates - portfolio update report & ai driven price forecasts baoquankhu1.vn Mon, 13 Apr 2026 17:12:08 GMT
• aug chart watch: what is aptevo therapeutics incs valuation compared to sector - 2026 reactions & smart money movement tracker baoquankhu1.vn Mon, 13 Apr 2026 14:18:05 GMT
• can aptevo (apvo) stock beat the market | price at $4.45, up 1.60% - insider info Cổng thông tin điện tử tỉnh Lào Cai Mon, 13 Apr 2026 07:00:00 GMT
• aug swings: is the honest company inc stock risky to hold now - market movement recap & real-time stock entry alerts baoquankhu1.vn Sat, 11 Apr 2026 17:18:50 GMT
• aptevo therapeutics (apvo) raised to buy: discover the reasons Bitget Sat, 11 Apr 2026 01:30:00 GMT
• Aptevo Therapeutics (APVO) Upgraded to Buy: Here's Why Yahoo Finance Fri, 10 Apr 2026 07:00:00 GMT
• Is Aptevo (APVO) Stock Showing Strength | Price at $4.45, Up 1.83% - OBV Divergence Město Břeclav Fri, 10 Apr 2026 07:00:00 GMT
• aptevo therapeutics (apvo) raised to buy: discover the reasons Bitget Fri, 10 Apr 2026 02:03:50 GMT
• tech rally: is aptevo therapeutics inc impacted by rising rates - 2026 sector review & real-time chart breakout alerts baoquankhu1.vn Thu, 09 Apr 2026 20:59:57 GMT
• apvo forecast, price target & analyst ratings | aptevo therapeutics inc (nasdaq:apvo) ChartMill Thu, 09 Apr 2026 07:00:00 GMT
• is aptevo (apvo) stock attractive now | price at $4.23, up 3.17% - single stock etf newsline.com Mon, 06 Apr 2026 07:00:00 GMT
• apvo forecast, price target & analyst ratings | aptevo therapeutics inc (nasdaq:apvo) ChartMill Thu, 02 Apr 2026 07:00:00 GMT
• apvo forecast, price target & analyst ratings | aptevo therapeutics inc (nasdaq:apvo) ChartMill Wed, 01 Apr 2026 07:00:00 GMT
• institution moves: will ibex outperform during market rallies - weekly risk summary & smart allocation stock tips baoquankhu1.vn Tue, 31 Mar 2026 18:15:21 GMT
• nasdaq moves: what are aptevo therapeutics incs recent sec filings showing - 2026 buyback activity & expert curated trade setups baoquankhu1.vn Tue, 31 Mar 2026 05:11:04 GMT
Aptevo Therapeutics Inc(NASDAQ:APVO) 
Aptevo Therapeutics Inc., a clinical-stage biotechnology company, focuses on developing immunotherapeutic candidates for the treatment of various forms of cancer in the United States. Its lead clinical candidate is APVO436, a bispecific T-cell engaging antibody candidate that is in Phase 1/1b clinic...
Website: http://aptevotherapeutics.com
Founded: 2016
Full Time Employees: 80
Sector: Healthcare
Industry: Biotechnology